AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29252823 — intervention group
Group type: COMPARATOR
Intervention: Standard visit control (group B)
Number of subjects: 48
Study 27997264 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (90 min bicycle ergometer test at 70% VO2max)
Number of subjects: 18
Study 27997264 — intervention group
Group type: COMPARATOR
Intervention: Control (resting situation)
Number of subjects: 18
Study 25179764 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided management (n = 176)
Number of subjects: 350
Study 25179764 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided standard care (n = 174)
Number of subjects: 350
Study 25179764 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided management
Number of subjects: 350
Study 25179764 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided standard care
Number of subjects: 350
Study 23852064 — intervention group
Group type: EXPERIMENTAL
Intervention: Empower self‐ligating technique (group A)
Number of subjects: 40
Study 23852064 — intervention group
Group type: COMPARATOR
Intervention: MBT technique (group B)
Number of subjects: 40
Study 21762151 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1%w/w o‐cymen‐5‐ol/ 0.6%w/w zinc chloride gel to foam dentifrice
Number of subjects: 205
Study 21762151 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluoride control dentifrice
Number of subjects: 205
Study 19282350 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab in combination with bevacizumab and chemotherapy
Number of subjects: 0
Study 19282350 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab and chemotherapy alone
Number of subjects: 0
Study 16622261 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate androgen deprivation (n = 493)
Number of subjects: 985
Study 16622261 — intervention group
Group type: COMPARATOR
Intervention: Deferred androgen deprivation (n = 492)
Number of subjects: 985
Study 14984449 — intervention group
Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (MUFA) diet
Number of subjects: 22
Study 14984449 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate (CHO) diet
Number of subjects: 22
Study 9106580 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 10 mg three times daily
Number of subjects: 20
Study 9106580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1642343 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 97
Study 1642343 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA)
Number of subjects: 97
Study 1642343 — intervention group
Group type: COMPARATOR
Intervention: Cold Ambient Operating Room Temperature
Number of subjects: 97
Study 1642343 — intervention group
Group type: COMPARATOR
Intervention: Advancing Patient Age
Number of subjects: 97
Study 1642343 — intervention group
Group type: COMPARATOR
Intervention: Warm Ambient Operating Room Temperature
Number of subjects: 97
Study 3472436 — intervention group
Group type: EXPERIMENTAL
Intervention: Home blood pressure (Home-BP) measured three times daily during a two week period
Number of subjects: 122
Study 3472436 — intervention group
Group type: COMPARATOR
Intervention: Out-patient clinic blood pressure (OPC-BP)
Number of subjects: 122
Study 30393062 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet treatment
Number of subjects: 2670
Study 30393062 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 2670
Study 30393062 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet treatment (users at baseline)
Number of subjects: 2670
Study 30393062 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment (users at baseline)
Number of subjects: 2670
Study 28532863 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory kinesiotaping
Number of subjects: 20
Study 28532863 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitatory kinesiotaping
Number of subjects: 20
Study 28532863 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both interventions
Number of subjects: 20
Study 26411991 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Action program
Number of subjects: 1246
Study 22413736 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural intervention (Internet self-management, bibliotherapy, group training)
Number of subjects: 304
Study 22413736 — intervention group
Group type: EXPERIMENTAL
Intervention: Group training
Number of subjects: 304
Study 22413736 — intervention group
Group type: COMPARATOR
Intervention: Control condition (information-only)
Number of subjects: 304
Study 21708364 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic computer simulator
Number of subjects: 0
Study 21708364 — intervention group
Group type: COMPARATOR
Intervention: Box trainer
Number of subjects: 0
Study 18452617 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Numeracy Test (DNT)
Number of subjects: 398
Study 18452617 — intervention group
Group type: EXPERIMENTAL
Intervention: DNT15 (shortened version of DNT)
Number of subjects: 398
Study 17071217 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence intervention involving symbolic modeling and vicarious reinforcement
Number of subjects: 128
Study 17071217 — intervention group
Group type: COMPARATOR
Intervention: Writing instructions only (Control)
Number of subjects: 128
Study 17071217 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence intervention
Number of subjects: 128
Study 15301657 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention
Number of subjects: 78
Study 15301657 — intervention group
Group type: COMPARATOR
Intervention: Standard psychoeducational counseling
Number of subjects: 78
Study 15301657 — intervention group
Group type: COMPARATOR
Intervention: Advice only
Number of subjects: 78
Study 10952095 — intervention group
Group type: EXPERIMENTAL
Intervention: Brassica vegetable diet
Number of subjects: 43
Study 10952095 — intervention group
Group type: EXPERIMENTAL
Intervention: Apiaceous vegetable diet
Number of subjects: 43
Study 10952095 — intervention group
Group type: EXPERIMENTAL
Intervention: Allium vegetable diet
Number of subjects: 43
Study 10952095 — intervention group
Group type: COMPARATOR
Intervention: Vegetable diets (overall)
Number of subjects: 43
Study 8899382 — intervention group
Group type: COMPARATOR
Intervention: Self-reported exposure to truck traffic (frequent and constant)
Number of subjects: 3703
Study 8899382 — intervention group
Group type: COMPARATOR
Intervention: Self-reported exposure to traffic noise
Number of subjects: 3703
Study 10895736 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg tablets once per day
Number of subjects: 0
Study 10895736 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole 10 mg troches five times per day
Number of subjects: 0
Study 3899840 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral indomethacin (total 200 mg) and chloroquine (total 1.5 g)
Number of subjects: 29
Study 3899840 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 29
Study 3538324 — intervention group
Group type: EXPERIMENTAL
Intervention: SLO4 oral drops
Number of subjects: 60
Study 31475507 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior QLB + intravenous PCA morphine (Group B)
Number of subjects: 60
Study 31475507 — intervention group
Group type: COMPARATOR
Intervention: Intravenous PCA morphine (Group C)
Number of subjects: 60
Study 28426917 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy (iCBT) program for depression added to treatment as usual (TAU)
Number of subjects: 69
Study 28426917 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 69
Study 28190255 — intervention group
Group type: EXPERIMENTAL
Intervention: IXEQ2W/IXEQ4W
Number of subjects: 1226
Study 28190255 — intervention group
Group type: COMPARATOR
Intervention: IXEQ4W
Number of subjects: 1226
Study 28190255 — intervention group
Group type: EXPERIMENTAL
Intervention: IXEQ2W/PBO/IXEQ4W
Number of subjects: 1226
Study 28190255 — intervention group
Group type: EXPERIMENTAL
Intervention: IXEQ4W/PBO/IXEQ4W
Number of subjects: 1226
Study 26021225 — intervention group
Group type: COMPARATOR
Intervention: Protocol A (no other antibiotic administration)
Number of subjects: 360
Study 26021225 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (1 g of amoxicillin in the evening of the day of surgery and 1 g twice a day for 2 days after)
Number of subjects: 360
Study 26021225 — intervention group
Group type: COMPARATOR
Intervention: Protocol A
Number of subjects: 360
Study 26021225 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B
Number of subjects: 360
Study 23249768 — intervention group
Group type: EXPERIMENTAL
Intervention: Drop jump protocol with 1 set per 5 repetitions
Number of subjects: 10
Study 23249768 — intervention group
Group type: EXPERIMENTAL
Intervention: Drop jump protocol with 2 sets per 5 repetitions
Number of subjects: 10
Study 21693723 — intervention group
Group type: EXPERIMENTAL
Intervention: Predischarge HF score for subsequent death or unfavorable QoL
Number of subjects: 1458
Study 21693723 — intervention group
Group type: EXPERIMENTAL
Intervention: KCCQ scores <45 at 1 and 24 weeks after hospital discharge
Number of subjects: 1458
Study 21693723 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality within 6 months
Number of subjects: 1458
Study 18803892 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraumbilical vein syntocinon 10 units
Number of subjects: 500
Study 18803892 — intervention group
Group type: COMPARATOR
Intervention: Intravenous 5 IU oxytocin + 0.5 mg ergometrine
Number of subjects: 500
Study 16580284 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral analgesia with oxycodone‐acetaminophen
Number of subjects: 93
Study 16580284 — intervention group
Group type: COMPARATOR
Intervention: Morphine patient‐controlled analgesia device
Number of subjects: 93
Study 14529984 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine with epinephrine
Number of subjects: 119
Study 14529984 — intervention group
Group type: COMPARATOR
Intervention: Saline with epinephrine
Number of subjects: 119
Study 10893592 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 biopsy cores
Number of subjects: 244
Study 10893592 — intervention group
Group type: COMPARATOR
Intervention: 12 biopsy cores
Number of subjects: 244
Study 8941068 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,2-propanediol-treated (group 2)
Number of subjects: 98
Study 8941068 — intervention group
Group type: COMPARATOR
Intervention: Control (group 1)
Number of subjects: 98
Study 8941068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreserved (group 3)
Number of subjects: 98
Study 1357554 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (42 micrograms twice daily)
Number of subjects: 234
Study 1357554 — intervention group
Group type: COMPARATOR
Intervention: Albuterol (180 micrograms four times daily)
Number of subjects: 234
Study 1357554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 3914251 — intervention group
Group type: EXPERIMENTAL
Intervention: Niridazole
Number of subjects: 26
Study 3914251 — intervention group
Group type: COMPARATOR
Intervention: Conventional steroid and azathioprine therapy
Number of subjects: 26
Study 31483884 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-phase integrated weight management programme delivered within routine primary care
Number of subjects: 0
Study 31483884 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-phase integrated weight management programme
Number of subjects: 0
Study 27977284 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls Aspiring toward Independence (GAIN) intervention
Number of subjects: 27
Study 27977284 — intervention group
Group type: COMPARATOR
Intervention: Usual care condition
Number of subjects: 27
Study 25882919 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice capsules (2 capsules, 2 times a day for 6 weeks)
Number of subjects: 160
Study 25882919 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo, 2 capsules, 2 times a day for 6 weeks)
Number of subjects: 160
Study 23667192 — intervention group
Group type: EXPERIMENTAL
Intervention: OMT group
Number of subjects: 53
Study 23667192 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo group
Number of subjects: 53
Study 23667192 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 21301848 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal cisplatin 200 mg/m2 combined with paclitaxel 135 mg/m2
Number of subjects: 202
Study 21301848 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin 75 mg/m2 combined with paclitaxel 135 mg/m2
Number of subjects: 202
Study 19625240 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate therapy (10 mg daily)
Number of subjects: 9
Study 19625240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 17052777 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (50% of CONSENSUS II patients)
Number of subjects: 9915
Study 17052777 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group in CONSENSUS II)
Number of subjects: 9915
Study 17052777 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurohormonal blockade (ACEi and beta-blockade in 4S)
Number of subjects: 9915
Study 17052777 — intervention group
Group type: COMPARATOR
Intervention: No neurohormonal blockade (control group in 4S)
Number of subjects: 9915
Study 15045685 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide GITS (5 mg/d)
Number of subjects: 18
Study 15045685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 11684630 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (nonselective beta-blocker)
Number of subjects: 36
Study 11684630 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (selective beta-blocker)
Number of subjects: 36
Study 11684630 — intervention group
Group type: EXPERIMENTAL
Intervention: Both carvedilol and metoprolol
Number of subjects: 36
Study 11684630 — intervention group
Group type: COMPARATOR
Intervention: Neither carvedilol nor metoprolol
Number of subjects: 36
Study 14518350 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimetinden/cimetidine
Number of subjects: 60
Study 14518350 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimetinden/famotidine
Number of subjects: 60
Study 14518350 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimetinden/ranitidine
Number of subjects: 60
Study 7814117 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of stannous fluoride (SnF2) and silver diamine fluoride (SDF)
Number of subjects: 0
Study 7814117 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of stannous fluoride (SnF2) and composite resin
Number of subjects: 0
Study 7814117 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal cavity preparation and composite resin only
Number of subjects: 0
Study 7814117 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 2773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol (equal to about two egg yolks daily)
Number of subjects: 25
Study 2773832 — intervention group
Group type: COMPARATOR
Intervention: High saturated fatty acids diet
Number of subjects: 25
Study 2773832 — intervention group
Group type: COMPARATOR
Intervention: Modified fat content and fatty acid composition diet
Number of subjects: 25
Study 2773832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cholesterol
Number of subjects: 25
Study 326215 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 40
Study 326215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31407195 — intervention group
Group type: EXPERIMENTAL
Intervention: Boswellic acids (BAs)
Number of subjects: 80
Study 31407195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 27439382 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced 2-hour childbirth education at the maternity hospital
Number of subjects: 659
Study 27439382 — intervention group
Group type: COMPARATOR
Intervention: Regular childbirth education
Number of subjects: 659
Study 25873343 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI plus endostar
Number of subjects: 40
Study 25873343 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI alone
Number of subjects: 40
Study 23756230 — intervention group
Group type: EXPERIMENTAL
Intervention: ronacaleret
Number of subjects: 0
Study 23756230 — intervention group
Group type: COMPARATOR
Intervention: rhPTH(1‐34)
Number of subjects: 0
Study 20954591 — intervention group
Group type: EXPERIMENTAL
Intervention: Topography-based LRI
Number of subjects: 36
Study 20954591 — intervention group
Group type: COMPARATOR
Intervention: Conventional LRI
Number of subjects: 36
Study 20954591 — intervention group
Group type: EXPERIMENTAL
Intervention: Topography-based LRI and Conventional LRI
Number of subjects: 36
Study 19437505 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐based cognitive‐behavioral treatment with minimal contact via e‐mail
Number of subjects: 52
Study 19437505 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 52
Study 17059385 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0
Study 17059385 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 0
Study 15311111 — intervention group
Group type: EXPERIMENTAL
Intervention: Examination of individual serial echocardiograms
Number of subjects: 210
Study 15311111 — intervention group
Group type: COMPARATOR
Intervention: Examination of all-patient mixed echocardiograms
Number of subjects: 210
Study 11758074 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement interventions (development and promulgation of clinical practice guidelines combined with regular audit and feedback)
Number of subjects: 0
Study 11758074 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement interventions
Number of subjects: 0
Study 9389841 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 13
Study 9389841 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 13
Study 8186348 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg long-acting (LA)
Number of subjects: 319
Study 8186348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study 3283917 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine, 400 mg twice daily
Number of subjects: 118
Study 3283917 — intervention group
Group type: COMPARATOR
Intervention: Novaluzid, 10 ml four times daily
Number of subjects: 118
Study 30146148 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 92
Study 30146148 — intervention group
Group type: COMPARATOR
Intervention: Active Control Condition (ACC)
Number of subjects: 92
Study 28661435 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine fortification
Number of subjects: 196
Study 25645436 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar tendon graft
Number of subjects: 68
Study 25645436 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstrings tendon graft
Number of subjects: 68
Study 25645436 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 68
Study 23900048 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic positron emission tomography imaging with (18)FDG
Number of subjects: 20
Study 23900048 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicholoroacetate and 2 tyrosine kinase inhibitors (imatinib and sunitinib)
Number of subjects: 20
Study 23900048 — intervention group
Group type: EXPERIMENTAL
Intervention: Dicholoroacetate and imatinib
Number of subjects: 20
Study 21138902 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral shoulder position
Number of subjects: 361
Study 21138902 — intervention group
Group type: COMPARATOR
Intervention: Lowered shoulder position
Number of subjects: 361
Study 18978612 — intervention group
Group type: COMPARATOR
Intervention: Treadmill running (TR) test
Number of subjects: 10
Study 18978612 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-country roller-skiing (RS) test
Number of subjects: 10
Study 17136615 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconferencing
Number of subjects: 581
Study 17136615 — intervention group
Group type: EXPERIMENTAL
Intervention: Online learning
Number of subjects: 581
Study 17136615 — intervention group
Group type: COMPARATOR
Intervention: Conference lectures
Number of subjects: 581
Study 17136615 — intervention group
Group type: COMPARATOR
Intervention: Instructor-led small group outreach sessions
Number of subjects: 581
Study 14737728 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5‐1cm deep marker injection
Number of subjects: 60
Study 14737728 — intervention group
Group type: COMPARATOR
Intervention: Sub‐epithelial marker injection
Number of subjects: 60
Study 10632651 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg, Amoxycillin 1 g, and Clarithromycin 500 mg (OAC) b.d. for 1 week
Number of subjects: 398
Study 10632651 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (Bismuth subcitrate 120 mg, Tetracycline 500 mg, Metronidazole 400 mg q.d.s. plus Omeprazole 20 mg b.d.)
Number of subjects: 398
Study 8959612 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused stimulation intervention administered by parents
Number of subjects: 25
Study 8959612 — intervention group
Group type: COMPARATOR
Intervention: Delayed-treatment (control) group
Number of subjects: 25
Study 7934140 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin treatment in vitro
Number of subjects: 14
Study 7934140 — intervention group
Group type: COMPARATOR
Intervention: Mitoxantrone, cytosine arabinoside ± carboplatin
Number of subjects: 14
Study 3287592 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion at a rate of 2 mU/kg/min with concomitant glucose infusion to maintain euglycaemia
Number of subjects: 8
Study 3287592 — intervention group
Group type: COMPARATOR
Intervention: Insulin infusion with falling blood glucose (no glucose infusion)
Number of subjects: 8
Study 31806733 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lumbar puncture
Number of subjects: 77
Study 31806733 — intervention group
Group type: COMPARATOR
Intervention: Landmark-based lumbar puncture
Number of subjects: 77
Study 31574581 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe uncorrected refractive error in non-Indigenous Australians
Number of subjects: 4836